Use of EP4 receptor ligands in the treatment of neuropathic pain and colon cancer
   
   

The present invention relates to the use of an EP4 receptor ligand in the manufacture of a medicament for use in the treatment of neuropathic pain, colon cancer, migraine, and for increasing the latency of HIV infection.

 
Web www.patentalert.com

< Treatment and prevention of HIV infection by administration of derivatives of human chorionic gonadotropin

< Anti-HIV pyrazole derivatives

> Endosomolytic agents and cell delivery systems

> Polymorphic and other crystalline forms cis-FTC
~ 00164